Susquehanna International Group
TERN

Susquehanna International Group’s Terns Pharmaceuticals TERN Stock Holding History

Susquehanna International Group’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.5M Buy
521,571
+513,974
+6,765% +$21.1M ﹤0.01% 1844
2025
Q4 		$307K Buy
+7,597
New +$176K ﹤0.01% 9893
2025
Q3 		– Sell
-87,623
Closed -$559K – 13860
2025
Q2 		$327K Sell
87,623
-3,551
-4% -$11.1K ﹤0.01% 10147
2025
Q1 		$252K Buy
91,174
+55,285
+154% +$226K ﹤0.01% 10456
2024
Q4 		$199K Sell
35,889
-9,989
-22% -$67.6K ﹤0.01% 10731
2024
Q3 		$383K Buy
45,878
+10,048
+28% +$82.7K ﹤0.01% 9089
2024
Q2 		$244K Buy
35,830
+16,087
+81% +$97.4K ﹤0.01% 9915
2024
Q1 		$130K Sell
19,743
-42,701
-68% -$279K ﹤0.01% 11030
2023
Q4 		$405K Buy
62,444
+23,338
+60% +$123K ﹤0.01% 9154
2023
Q3 		$197K Sell
39,106
-125,745
-76% -$798K ﹤0.01% 10248
2023
Q2 		$1.44M Sell
164,851
-163,177
-50% -$1.9M ﹤0.01% 5849
2023
Q1 		$3.88M Buy
328,028
+289,926
+761% +$2.77M ﹤0.01% 3837
2022
Q4 		$388K Buy
+38,102
New +$254K ﹤0.01% 8462

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Susquehanna International Group's TERN Position: Q1 2026 in Review

Susquehanna International Group increased its Terns Pharmaceuticals (TERN) stake by 6,765% in Q1 2026, buying an estimated $21.1M and bringing the position to 521,571 shares worth $27.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

Susquehanna International Group first reported a position in TERN in Q4 2022 and has held it in 13 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Susquehanna International Group held 521,571 shares of Terns Pharmaceuticals worth $27.5M as of Q1 2026.
  • Susquehanna International Group bought 513,974 Terns Pharmaceuticals shares in Q1 2026, an estimated $21.1M.
  • Terns Pharmaceuticals made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1844 holding.
  • Susquehanna International Group first reported a position in Terns Pharmaceuticals in Q4 2022 and has held it in 13 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.